Phenacemide: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
| verifiedrevid = 408804023 | | verifiedrevid = 408804023 | ||
| IUPAC_name = ''N''-carbamoyl-2-phenyl-acetamide | | IUPAC_name = ''N''-carbamoyl-2-phenyl-acetamide | ||
| image = Phenacemide. | | image = Phenacemide.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
Line 52: | Line 52: | ||
| StdInChIKey = XPFRXWCVYUEORT-UHFFFAOYSA-N | | StdInChIKey = XPFRXWCVYUEORT-UHFFFAOYSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Phenacemide''' is an [[anticonvulsant]] of the [[urea]] class. | '''Phenacemide''' is an [[anticonvulsant]] of the [[urea]] class. | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
==External links== | ==External links== | ||
Line 67: | Line 71: | ||
[[Category:Ureas]] | [[Category:Ureas]] | ||
[[Category: | [[Category:Drug]] | ||
{{anticonvulsant-stub}} | {{anticonvulsant-stub}} |
Latest revision as of 13:33, 10 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 22-25 hours. |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C9H10N2O2 |
Molar mass | 178.188 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Phenacemide |
Articles |
---|
Most recent articles on Phenacemide Most cited articles on Phenacemide |
Media |
Powerpoint slides on Phenacemide |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Phenacemide at Clinical Trials.gov Clinical Trials on Phenacemide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Phenacemide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Phenacemide Discussion groups on Phenacemide Patient Handouts on Phenacemide Directions to Hospitals Treating Phenacemide Risk calculators and risk factors for Phenacemide
|
Healthcare Provider Resources |
Causes & Risk Factors for Phenacemide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Phenacemide is an anticonvulsant of the urea class.
References
External links
- Template:DiseasesDB
- Template:MedlinePlusDrugInfo
- Coker S (1986). "The use of phenacemide for intractable partial complex epilepsy in children". Pediatr Neurol. 2 (4): 230–2. doi:10.1016/0887-8994(86)90053-6. PMID 3508693.
- Coker S, Holmes E, Egel R (1987). "Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations". Neurology. 37 (12): 1861–6. doi:10.1212/wnl.37.12.1861. PMID 3683877.